Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/2/2007
 
First Published:
8/10/2007
1.
Phase I/II Study of VNP40101M and Temozolomide in Patients With Progressive or Relapsed Malignant Glioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
Over 18
NCI
NU07C1
NU 07C1, NCT00516282
2.
Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
60 and over
Other
0702009008
VNP40101M, NCT00655395
Last Modified:
9/16/2008
 
First Published:
7/14/2006
3.
Phase II Study of VNP40101M Followed By Cytarabine in Older Patients With Poor-Risk, De Novo Acute Myeloid Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
60 and over
Pharmaceutical / Industry
VION-CLI-043
NCT00354276, EUDRACT-2006-001853-89
4.
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 to 65
Other
2005-0844
NCT00521859
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute